Currently we do not have imaging modalities that can accurately predict tissue at risk for the secondary damage during the injury expansion phase after trauma to the CNS. Our group with working with Dr. Christoph Hofstetter, a neurosurgeon clinician scientist, to develop biomarkers that can predict injury severity and identify tissue at risk for secondary damage after traumatic spinal cord injury in patients.
